FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes
PR Newswire (press release) SILVER SPRING, Md., Dec. 11, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric ... |
New York Times |
Why You Need the Flu Shot Every Year
New York Times Most people know: If you got a flu shot this year, next year you'll need it again. This is because the virus changes, usually rendering the previous year's vaccine partly or totally useless. And it's no secret that the flu vaccine's effectiveness falls ... |
News-Medical.net |
Bluebird, Celgene Myeloma Therapy Appears to Improve in Time
Bloomberg A novel therapy from Bluebird Bio Inc. and Celgene Corp. for patients nearing death from an aggressive form of blood cancer appears to get more effective over time, wiping out signs of disease in more than half of those treated in a small trial. A ... CAR T, immunotherapy bring new hope for multiple myeloma patients 'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study Two immunotherapy approaches for multiple myeloma show hope |
Yakima Herald-Republic |
Flu cases picking up in Yakima County, but there's still time to get your shot
Yakima Herald-Republic FILE - In this Friday, Sept. 22, 2017 file photo, a flu vaccine injection is administered at the Brownsville Events Center by a pharmacist in Brownsville, Texas. According to data released by the Centers for Disease Control and Prevention on Friday ... Flu Activity On The Rise In Georgia: CDC Will County Health Department: 2017-2018 flu season Flu season off to an early – and nasty – start |
Press Herald |
Hepatitis cases mount in wake of opioid epidemic
Press Herald Several types of the virus are being reported in increasing numbers, with the Maine CDC issuing a public notice Monday about a small but unusual spike in hepatitis A cases. By Joe LawlorStaff Writer. Follow on Twitter · Email Writer · 207-791-6376 ... |